- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x VFX: 1-[(1R)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol(Non-covalent)
- 6 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.2: 8 residues within 4Å:- Chain A: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.413
DMS.13: 8 residues within 4Å:- Chain B: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.14
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.413
DMS.24: 8 residues within 4Å:- Chain C: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.25
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.413
DMS.35: 8 residues within 4Å:- Chain D: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.36
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:D.413
- Water bridges: D:H.332, D:H.332
DMS.46: 8 residues within 4Å:- Chain E: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.47
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:D.413
- Water bridges: E:H.332, E:H.332
DMS.57: 8 residues within 4Å:- Chain F: P.92, R.328, G.329, Y.330, A.331, A.411, D.413
- Ligands: GOL.58
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:D.413
- Water bridges: F:H.332, F:H.332
- 42 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 9 residues within 4Å:- Chain A: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.2
Ligand excluded by PLIPGOL.4: 7 residues within 4Å:- Chain A: A.263, T.265, A.266, H.269, P.294
- Chain E: A.391
- Ligands: PEG.5
Ligand excluded by PLIPGOL.6: 8 residues within 4Å:- Chain A: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.5
Ligand excluded by PLIPGOL.7: 5 residues within 4Å:- Chain A: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.9: 6 residues within 4Å:- Chain A: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.10: 8 residues within 4Å:- Chain A: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.11: 6 residues within 4Å:- Chain A: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIPGOL.14: 9 residues within 4Å:- Chain B: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.13
Ligand excluded by PLIPGOL.15: 7 residues within 4Å:- Chain B: A.263, T.265, A.266, H.269, P.294
- Chain D: A.391
- Ligands: PEG.16
Ligand excluded by PLIPGOL.17: 8 residues within 4Å:- Chain B: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.16
Ligand excluded by PLIPGOL.18: 5 residues within 4Å:- Chain B: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.20: 6 residues within 4Å:- Chain B: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.21: 8 residues within 4Å:- Chain B: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.22: 6 residues within 4Å:- Chain B: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIPGOL.25: 9 residues within 4Å:- Chain C: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.24
Ligand excluded by PLIPGOL.26: 7 residues within 4Å:- Chain C: A.263, T.265, A.266, H.269, P.294
- Chain F: A.391
- Ligands: PEG.27
Ligand excluded by PLIPGOL.28: 8 residues within 4Å:- Chain C: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.27
Ligand excluded by PLIPGOL.29: 5 residues within 4Å:- Chain C: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.31: 6 residues within 4Å:- Chain C: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.32: 8 residues within 4Å:- Chain C: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.33: 6 residues within 4Å:- Chain C: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIPGOL.36: 9 residues within 4Å:- Chain D: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.35
Ligand excluded by PLIPGOL.37: 7 residues within 4Å:- Chain B: A.391
- Chain D: A.263, T.265, A.266, H.269, P.294
- Ligands: PEG.38
Ligand excluded by PLIPGOL.39: 8 residues within 4Å:- Chain D: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.38
Ligand excluded by PLIPGOL.40: 5 residues within 4Å:- Chain D: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.42: 6 residues within 4Å:- Chain D: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.43: 8 residues within 4Å:- Chain D: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.44: 6 residues within 4Å:- Chain D: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIPGOL.47: 9 residues within 4Å:- Chain E: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.46
Ligand excluded by PLIPGOL.48: 7 residues within 4Å:- Chain A: A.391
- Chain E: A.263, T.265, A.266, H.269, P.294
- Ligands: PEG.49
Ligand excluded by PLIPGOL.50: 8 residues within 4Å:- Chain E: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.49
Ligand excluded by PLIPGOL.51: 5 residues within 4Å:- Chain E: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.53: 6 residues within 4Å:- Chain E: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.54: 8 residues within 4Å:- Chain E: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.55: 6 residues within 4Å:- Chain E: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIPGOL.58: 9 residues within 4Å:- Chain F: V.91, P.92, G.93, E.94, P.207, S.412, D.413, V.414
- Ligands: DMS.57
Ligand excluded by PLIPGOL.59: 7 residues within 4Å:- Chain C: A.391
- Chain F: A.263, T.265, A.266, H.269, P.294
- Ligands: PEG.60
Ligand excluded by PLIPGOL.61: 8 residues within 4Å:- Chain F: L.157, R.262, I.288, T.289, H.290, Q.417, T.418
- Ligands: PEG.60
Ligand excluded by PLIPGOL.62: 5 residues within 4Å:- Chain F: H.125, A.129, R.317, M.319, R.373
Ligand excluded by PLIPGOL.64: 6 residues within 4Å:- Chain F: R.57, V.60, P.61, T.62, D.63, A.65
Ligand excluded by PLIPGOL.65: 8 residues within 4Å:- Chain F: F.44, S.103, F.104, V.105, H.139, S.141, Y.146, F.422
Ligand excluded by PLIPGOL.66: 6 residues within 4Å:- Chain F: A.367, E.368, E.370, R.396, T.397, K.398
Ligand excluded by PLIP- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.5: 10 residues within 4Å:- Chain A: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.4, GOL.6
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:T.289
- Water bridges: A:L.261, A:I.288
PEG.8: 5 residues within 4Å:- Chain A: T.58, L.59, V.60, P.61, D.86
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.59
- Water bridges: A:R.57, A:T.58
PEG.16: 10 residues within 4Å:- Chain B: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.15, GOL.17
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:T.289
- Water bridges: B:L.261, B:I.288
PEG.19: 5 residues within 4Å:- Chain B: T.58, L.59, V.60, P.61, D.86
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.59
- Water bridges: B:R.57, B:T.58
PEG.27: 10 residues within 4Å:- Chain C: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.26, GOL.28
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:T.289
- Water bridges: C:L.261, C:I.288
PEG.30: 5 residues within 4Å:- Chain C: T.58, L.59, V.60, P.61, D.86
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:L.59
- Water bridges: C:R.57, C:T.58
PEG.38: 10 residues within 4Å:- Chain D: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.37, GOL.39
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:D.293
- Water bridges: D:L.261, D:I.288
PEG.41: 5 residues within 4Å:- Chain D: T.58, L.59, V.60, P.61, D.86
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:L.59
- Water bridges: D:R.57, D:T.58, D:D.86
PEG.49: 10 residues within 4Å:- Chain E: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.48, GOL.50
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:D.293
- Water bridges: E:L.261, E:I.288
PEG.52: 5 residues within 4Å:- Chain E: T.58, L.59, V.60, P.61, D.86
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:L.59
- Water bridges: E:R.57, E:T.58, E:D.86
PEG.60: 10 residues within 4Å:- Chain F: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: GOL.59, GOL.61
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:D.293
- Water bridges: F:L.261, F:I.288
PEG.63: 5 residues within 4Å:- Chain F: T.58, L.59, V.60, P.61, D.86
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:L.59
- Water bridges: F:R.57, F:T.58, F:D.86
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-01
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x VFX: 1-[(1R)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol(Non-covalent)
- 6 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 42 x GOL: GLYCEROL(Non-functional Binders)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-01
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A